Annual EBITDA
-$26.06 M
+$11.82 M+31.20%
31 December 2023
Summary:
Mereo BioPharma annual earnings before interest, taxes, depreciation & amortization is currently -$26.06 million, with the most recent change of +$11.82 million (+31.20%) on 31 December 2023. During the last 3 years, it has risen by +$189.91 million (+87.94%). MREO annual EBITDA is now -202.23% below its all-time high of $25.49 million, reached on 31 December 2021.MREO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$14.37 M
-$2.70 M-23.13%
30 September 2024
Summary:
Mereo BioPharma quarterly earnings before interest, taxes, depreciation & amortization is currently -$14.37 million, with the most recent change of -$2.70 million (-23.13%) on 30 September 2024. Over the past year, it has dropped by -$8.82 million (-158.89%). MREO quarterly EBITDA is now -3085.37% below its all-time high of -$451.00 thousand, reached on 30 June 2023.MREO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$43.41 M
-$8.82 M-25.49%
30 September 2024
Summary:
Mereo BioPharma TTM earnings before interest, taxes, depreciation & amortization is currently -$43.41 million, with the most recent change of -$8.82 million (-25.49%) on 30 September 2024. Over the past year, it has dropped by -$26.36 million (-154.60%). MREO TTM EBITDA is now -292.85% below its all-time high of -$11.05 million, reached on 21 March 2023.MREO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MREO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.2% | -158.9% | -154.6% |
| 3 y3 years | +87.9% | - | - |
| 5 y5 years | +40.0% | - | - |
MREO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -202.2% | +87.9% | -3085.4% | at low | -292.9% | at low |
| 5 y | 5 years | -202.2% | +87.9% | -3085.4% | at low | -292.9% | at low |
| alltime | all time | -202.2% | +87.9% | -3085.4% | at low | -292.9% | at low |
Mereo BioPharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$14.37 M(+23.1%) | -$43.41 M(+25.5%) |
| June 2024 | - | -$11.67 M(+39.5%) | -$34.59 M(+48.0%) |
| Mar 2024 | - | -$8.37 M(-7.1%) | -$23.37 M(-10.3%) |
| Dec 2023 | -$26.06 M(-31.2%) | -$9.01 M(+62.3%) | -$26.06 M(+52.8%) |
| Sept 2023 | - | -$5.55 M(+1130.4%) | -$17.05 M(+48.3%) |
| June 2023 | - | -$451.00 K(-95.9%) | -$11.50 M(+4.1%) |
| Mar 2023 | - | -$11.05 M | -$11.05 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$37.87 M(-248.6%) | - | - |
| Dec 2021 | $25.49 M(-111.8%) | - | - |
| Dec 2020 | -$215.96 M(+374.3%) | - | - |
| Dec 2019 | -$45.53 M(+4.9%) | - | - |
| Dec 2018 | -$43.41 M(-30.8%) | - | - |
| Dec 2017 | -$62.73 M(+51.7%) | - | - |
| Dec 2016 | -$41.34 M | - | - |
FAQ
- What is Mereo BioPharma annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Mereo BioPharma?
- What is Mereo BioPharma annual EBITDA year-on-year change?
- What is Mereo BioPharma quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Mereo BioPharma?
- What is Mereo BioPharma quarterly EBITDA year-on-year change?
- What is Mereo BioPharma TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Mereo BioPharma?
- What is Mereo BioPharma TTM EBITDA year-on-year change?
What is Mereo BioPharma annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of MREO is -$26.06 M
What is the all time high annual EBITDA for Mereo BioPharma?
Mereo BioPharma all-time high annual earnings before interest, taxes, depreciation & amortization is $25.49 M
What is Mereo BioPharma annual EBITDA year-on-year change?
Over the past year, MREO annual earnings before interest, taxes, depreciation & amortization has changed by +$11.82 M (+31.20%)
What is Mereo BioPharma quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of MREO is -$14.37 M
What is the all time high quarterly EBITDA for Mereo BioPharma?
Mereo BioPharma all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$451.00 K
What is Mereo BioPharma quarterly EBITDA year-on-year change?
Over the past year, MREO quarterly earnings before interest, taxes, depreciation & amortization has changed by -$8.82 M (-158.89%)
What is Mereo BioPharma TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of MREO is -$43.41 M
What is the all time high TTM EBITDA for Mereo BioPharma?
Mereo BioPharma all-time high TTM earnings before interest, taxes, depreciation & amortization is -$11.05 M
What is Mereo BioPharma TTM EBITDA year-on-year change?
Over the past year, MREO TTM earnings before interest, taxes, depreciation & amortization has changed by -$26.36 M (-154.60%)